Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq–guided combination with sapanisertib

The therapeutic potential of CDK4/6 inhibitors for brain tumors has been limited by recurrence. To address recurrence, we tested a nanoparticle formulation of CDK4/6 inhibitor palbociclib (POx-Palbo) in mice genetically-engineered to develop SHH-driven medulloblastoma, alone or in combination with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Chaemin, Dismuke, Taylor, Malawsky, Daniel, Ramsey, Jacob D., Hwang, Duhyeong, Godfrey, Virginia L., Kabanov, Alexander V., Gershon, Timothy R., Sokolsky-Papkov, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791615/
https://www.ncbi.nlm.nih.gov/pubmed/35080986
http://dx.doi.org/10.1126/sciadv.abl5838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791615/
https://www.ncbi.nlm.nih.gov/pubmed/35080986
http://dx.doi.org/10.1126/sciadv.abl5838

Ejemplares similares